Related Experiment Videos
The pathogenesis of bleomycin-induced pulmonary fibrosis in mice
Abstract:
Administration of 0.5 mg bleomycin to mice twice weekly for 4 weeks induced pulmonary fibrosis. The initial site of injury was the intima of pulmonary arteries and veins where endothelial cells became edematous and were separated from the underlying basement membrane by large blebs. These lesions occurred after 2 weeks and were associated with infiltration of perivascular spaces by lymphocytes and plasma cells. Capillary endothelial blebbing and interstitial edema were observed after 4 weeks, when multifocal necrosis of type 1 alveolar epithelial cells was accompanied by fibrinous exudation into the alveoli. The process of repair was characterized by proliferation and metaplasia of type 2 epithelial cells, fibroblastic organization of alveolar fibrin and fibrosis of the interstitium within 8 to 12 weeks. The consistent induction of changes similar to those of diffuse pulmonary fibrosis or fibrosing alveolitis in man suggests that bleomycin-induced injury may provide a suitable model for the investigation of this ill-defined group of diseases.
Insights
Bleomycin administration in mice caused pulmonary fibrosis, mimicking human fibrosing alveolitis. This bleomycin-induced lung injury model is valuable for studying diffuse pulmonary fibrosis.
Area of Science:
- Pulmonary Pathology
- Toxicology
- Animal Models
Background:
- Diffuse pulmonary fibrosis and fibrosing alveolitis are poorly understood human lung diseases.
- Investigating the mechanisms of pulmonary fibrosis requires suitable experimental models.
Purpose of the Study:
- To characterize the temporal development of bleomycin-induced pulmonary fibrosis in mice.
- To evaluate the utility of bleomycin-induced lung injury as a model for human fibrosing alveolitis.
Main Methods:
- Mice were administered 0.5 mg of bleomycin twice weekly for 4 weeks.
- Histopathological analysis was performed at various time points to assess lung injury and repair.
Main Results:
- Bleomycin induced initial injury to pulmonary vascular intima, followed by interstitial edema and alveolar damage.
- Repair involved type 2 epithelial cell proliferation, fibroblastic organization, and interstitial fibrosis.
- The induced pathology closely resembled human diffuse pulmonary fibrosis and fibrosing alveolitis.
Conclusions:
- Bleomycin consistently induces pulmonary fibrosis in mice.
- This bleomycin-induced lung injury model is suitable for investigating the pathogenesis of diffuse pulmonary fibrosis and fibrosing alveolitis.